The mutation frequency is highest in MDS and particularly in MDS with ring sideroblasts (MDS-RS) [1]; therefore, SF3B1 mutations are now used to define a distinct clinical entity of MDS-RS [2,45]. Here, SF3B1 is linked to myelodysplastic syndrome.